Jeffrey Lieberman | |
|---|---|
 | |
| Born | 1948 (age 75–76) |
| Education | Miami University (BS) George Washington University (MD) |
| Known for | Schizophrenia research NIMH CATIE study[1] |
| Children | 2 |
| Awards | Lieber Prize for Schizophrenia Research from the National Association for Research in Schizophrenia and Affective Disorders Adolph Meyer Award from the American Psychiatric Association Research Award from the National Alliance on Mental Illness |
| Scientific career | |
| Fields | Psychiatry |
| Institutions | American Psychiatric Association Columbia University Vagelos College of Physicians and Surgeons New York State Psychiatric Institute University of North Carolina School of Medicine Mount Sinai School of Medicine Albert Einstein College of Medicine Zucker Hillside Hospital |
Jeffrey Alan Lieberman (born 1948) is an American psychiatrist who specializes in schizophrenia and related psychoses and their associated neuroscience (biology) and pharmacological treatment (psychiatric drugs). He was principal investigator for CATIE, the largest and longest independent study ever funded by the United States National Institute of Mental Health to examine existing pharmacotherapies for schizophrenia.[2] He was president of the American Psychiatric Association from May 2013 to May 2014.[3]
- ^ "Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)". National Institute of Mental Health. 2005–2008. Archived from the original on May 26, 2013. Retrieved May 26, 2013.
- ^ "Questions and Answers About the NIMH Clinical Antipsychotic Trials of Intervention Effectiveness Study (CATIE) — Phase 1 Results". National Institute of Mental Health, U.S. Department of Health and Human Services. September 2005. Archived from the original on May 26, 2013. Retrieved May 28, 2013.
- ^ "Jeffrey A. Lieberman". Columbia University. Retrieved May 26, 2013.